Followers | 516 |
Posts | 6869 |
Boards Moderated | 0 |
Alias Born | 01/24/2008 |
Tuesday, June 02, 2020 1:46:14 PM
All IMO,
DD22
Recent ALRN News
- Aileron Therapeutics to Present at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million • GlobeNewswire Inc. • 05/03/2024 08:05:00 PM
- Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced At-The-Market Under Nasdaq Rules of up to Approximately $40 Million • GlobeNewswire Inc. • 05/01/2024 12:45:03 PM
- Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) • GlobeNewswire Inc. • 05/01/2024 12:30:23 PM
- Aileron Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/15/2024 09:20:25 PM
- Aileron Therapeutics Announces CEO Transition • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:01:03 PM
- Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event • GlobeNewswire Inc. • 02/15/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 12:01:03 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/06/2024 05:15:26 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/05/2024 06:20:21 PM
- Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024 • GlobeNewswire Inc. • 02/01/2024 09:30:50 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/31/2024 09:05:32 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/29/2024 09:15:07 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/29/2024 09:10:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/29/2024 01:46:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:14:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 12:00:32 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 01/19/2024 09:44:28 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/11/2024 09:18:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:08:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 10:56:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:43:12 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM